Cytokines in Cancer Immunotherapy

Cited by (504)

Items 101–200 of 504

1. Adverse Events of Oncologic Immunotherapy and Their Management
   Fedricker Diane Barber · 2019 · Asia-Pacific Journal of Oncology Nursing
2. Polymeric Micelles in Cancer Immunotherapy
   Zhuoya Wan, Ruohui Zheng, Pearl Moharil, Yuzhe Liu, Jing Chen, Runzi Sun, Xu Song, Qiang Ao · 2021 · Molecules
3. Radiotherapy in Combination With Cytokine Treatment
   Ondřej Palata, Nada Podzimkova, Eva Nedvedova, Alexandra Umprecht, Lenka Kyrych Sadilkova, Lenka Palova Jelinkova, Radek Špíšek, Irena Adkins · 2019 · Frontiers in Oncology
4. The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy?
   Shunchuan Zhang, Samuel D. Rabkin · 2020 · Expert Opinion on Drug Discovery
5. The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies
   Oliviero Marinelli, Daniela Annibali, Cristina Aguzzi, Sandra Tuyaerts, Frédéric C. Amant, Maria Beatrice Morelli, Giorgio Santoni, Consuelo Amantini, Federica Maggi, Massimo Nabissi · 2019 · Frontiers in Oncology
6. Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice
   Lisa Munakata, Yoshihiko Tanimoto, Akio Osa, Jie Meng, Yasunari Haseda, Yujiro Naito, Hirotomo Machiyama, Atsushi Kumanogoh, Daiki Omata, Kazuo Maruyama et al. · 2019 · Journal of Controlled Release
7. Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
   Karin M. Knudson, Kristin C. Hicks, Yohei Ozawa, Jeffrey Schlom, Sofia R. Gameiro · 2020 · Journal for ImmunoTherapy of Cancer
8. Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
   Tianqi Wang, Yusuke Suita, Saradha Miriyala, Jordan Dean, Nikos Tapinos, Jie Shen · 2021 · Pharmaceutics
9. Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response
   Piper A. Rawding, Jiyoon Bu, Jianxin Wang, DaWon Kim, Adam J. Drelich, Young Soo Kim, Seungpyo Hong · 2021 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
10. Effects of 3‐HAA on HCC by Regulating the Heterogeneous Macrophages—A scRNA‐Seq Analysis
    Chen Xue, Xinyu Gu, Qiuxian Zheng, Qingmiao Shi, Xin Yuan, Qingfei Chu, Junjun Jia, Yuanshuai Su, Zhengyi Bao, Juan Lu et al. · 2023 · Advanced Science
11. Current Development Status of Cytokines for Cancer Immunotherapy
    Kyoung Song · 2023 · Biomolecules & Therapeutics
12. Nanoparticle-based approaches to target the lymphatic system for antitumor treatment
    Xingzhou Peng, Junjie Wang, Feifan Zhou, Qian Liu, Zhihong Zhang · 2021 · Cellular and Molecular Life Sciences
13. The dark side of immunotherapy
    Nwanneka Okwundu, Douglas Grossman, Siwen Hu‐Lieskovan, Kenneth F. Grossmann, Umang Swami · 2021 · Annals of Translational Medicine
14. RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells
    Zhengkui Zhang, Xiangjun Kong, Maarten Alexander Ligtenberg, Susan E. van Hal-van Veen, Nils L. Visser, Beaunelle de Bruijn, Kelly E. Stecker, Pim W. van der Helm, Thomas Kuilman, Esmée P. Hoefsmit et al. · 2022 · Cell Reports Medicine
15. An Optogenetic Controllable T Cell System for Hepatocellular Carcinoma Immunotherapy
    Bixing Zhao, Yingchao Wang, Xionghong Tan, Xiaoyuan Zheng, Fei Wang, Kun Ke, Cuilin Zhang, Naishun Liao, Yuan Dang, Yingjun Shi et al. · 2019 · Theranostics
16. T cell immunotherapy enhanced by designer biomaterials
    Zachary Spencer Dunn, John Mac, Pin Wang · 2019 · Biomaterials
17. Functional immune mapping with deep-learning enabled phenomics applied to immunomodulatory and COVID-19 drug discovery
    Michael F. Cuccarese, Berton A. Earnshaw, Katie Heiser, Ben Fogelson, Chadwick T. Davis, Peter McLean, Hannah B. Gordon, Kathleen-Rose Skelly, Fiona L. Weathersby, Vlad Rodic et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
18. Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing
    Rilan Bai, Jiuwei Cui · 2022 · Frontiers in Immunology
19. Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology
    Eden Mariam Jacob, Jiaoti Huang, Ming Chen · 2024 · Precision Clinical Medicine
20. MicroRNAs, Multiple Sclerosis, and Depression
    Hsiuying Wang · 2021 · International Journal of Molecular Sciences
21. Cytokine concentration in peripheral blood of patients with colorectal cancer
    Wenchang Li, Fangqian Chen, Han Gao, Zhuoqing Xu, Yu Zhou, Shenjie Wang, Zeping Lv, Yuchen Zhang, Zifeng Xu, Jianting Huo et al. · 2023 · Frontiers in Immunology
22. Lymph nodes: at the intersection of cancer treatment and progression
    Nathan Edward Reticker-Flynn, Edgar G. Engleman · 2023 · Trends in Cell Biology
23. Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions
    Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim, Jasur Alimdjanovich Rizaev, Dmitry Olegovich Bokov, Ahmed M. Hjazi, Shriya Mahajan, Yasser Fakri Mustafa, Beneen Husseen, Mohammed Abed Jawad · 2024 · Critical Reviews in Oncology/Hematology
24. Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies
    Sigrid P. Dubois, Miloš D. Miljković, Thomas A. Fleisher, Stefania Pittaluga, Jennifer Hsu-Albert, Bonita R. Bryant, Michael N. Petrus, Liyanage P. Perera, Jürgen R. Müller, Joanna H. Shih et al. · 2021 · Journal for ImmunoTherapy of Cancer
25. Peripheral cytokine levels as novel predictors of survival in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
    Xin‐Cheng Mao, Chuncheng Yang, Yafei Yang, Lun‐Jie Yan, Zi‐Niu Ding, Hui Liu, Yu‐Chuan Yan, Zhao‐Ru Dong, Dongxu Wang, Tao Li · 2022 · Frontiers in Immunology
26. Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
    Xin Su, Jian Li, Xiao Xu, Youbao Ye, Cailiu Wang, Guanglong Pang, Wenxiu Liu, Ang Liu, Changchun Zhao, Xiangyong Hao · 2024 · Journal of Translational Medicine
27. Natural killer cell-based cancer immunotherapy: from basics to clinical trials
    Ying–Hong Shi, Donglin Hao, Hui Qian, Zhimin Tao · 2024 · Experimental Hematology and Oncology
28. Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements
    Yang Wang, Na Zhu, Jing Liu, Fang Chen, Yang Song, Yue Ma, Zhuo Yang, Danbo Wang · 2025 · Journal of Translational Medicine
29. Common gamma chain cytokines and CD8 T cells in cancer
    Mitra Shourian, Jean‐Christophe Beltra, Benoîte Bourdin, Hélène Decaluwe · 2019 · Seminars in Immunology
30. Interleukin 2-Based Fusion Proteins for the Treatment of Cancer
    Alana MacDonald, T.‐C. Wu, Chien‐Fu Hung · 2021 · Journal of Immunology Research
31. Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response
    Robert B. Rebhun, Daniel S. York, Sylvia M. Cruz, Sean James Judge, Aryana M. Razmara, Lauren E Farley, Rachel V. Brady, Eric G. Johnson, Jenna H. Burton, Jennifer L. Willcox et al. · 2022 · Journal for ImmunoTherapy of Cancer
32. Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
    Minglei Zhao, Hui Huang, Feng He, Xiangsheng Fu · 2023 · Frontiers in Immunology
33. Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication
    Meysam Mosallaei, Miganoosh Simonian, Naeim Ehtesham, Mohammad Reza Karimzadeh, Nasimeh Vatandoost, Babak Negahdari, Rasoul Salehi · 2020 · Cancer Gene Therapy
34. Modulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment
    Théo Accogli, Mélanie Bruchard, Frédérique Végran · 2021 · Cancers
35. Cytokine chemokine network in tumor microenvironment: Impact on CSC properties and therapeutic applications
    Mushtaq Ahmad Nengroo, Ayushi Verma, Dipak B. Datta · 2022 · Cytokine
36. A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity
    Wenqiang Shi, Liangyin Lv, Nan Liu, Hui Wang, Yang Wang, Wen Zhu, Zexin Liu, Jianwei Zhu, Huili Lu · 2022 · Molecular Therapy
37. Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring
    Sajida Maryam, Katarzyna Krukiewicz, Ihtisham Ul Haq, Awal Ayaz Khan, Galal Yahya, Simona Daniela Cavalu · 2023 · Journal of Clinical Medicine
38. Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
    Vanessa Acebes-Fernández, Alicia Landeira‐Viñuela, Pablo Juanes‐Velasco, Ángela‐Patricia Hernández, Andrea Otazo‐Pérez, Raúl Manzano-Román, Rafael Góngora, Manuel Fuentes · 2020 · Nanomaterials
39. Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
    Ji‐Yoon Noh, Huiyun Seo, Jungwoon Lee, Haiyoung Jung · 2020 · International Journal of Molecular Sciences
40. Engineered Multifunctional Nano‐ and Biological Materials for Cancer Immunotherapy
    Anthony Brouillard, Nilesh Deshpande, Ashish A. Kulkarni · 2021 · Advanced Healthcare Materials
41. Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles
    Kwang-Soo Kim, Dong‐Hwan Kim, Dong‐Hyun Kim · 2021 · Pharmaceutics
42. Development of Platinum Complexes for Tumor Chemoimmunotherapy
    S. Jin, Yan Guo, Xiaoyong Wang · 2024 · Chemistry - A European Journal
43. The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management
    Amin Ullah, Wang Jiao, Bairong Shen · 2024 · Cellular & Molecular Biology Letters
44. Targeting T Cell Activation in Immuno-Oncology
    Samuel David Saibil, Pamela S. Ohashi · 2020 · Current Oncology
45. Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies
    Huijie Han, Hélder A. Santos · 2024 · Advanced Materials
46. A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies
    Jiaxi Wu, Nicolin Bloch, Aaron Y. Chang, Ramandeep Bhavsar, Qingqing Wang, Alison Crawford, David J. DiLillo, Kristin Vazzana, Katja Mohrs, Drew Dudgeon et al. · 2024 · Cell Reports Medicine
47. Stimuli-responsive nanomaterials for the precision delivery of mRNA cancer vaccines
    Ruby Srivastava · 2025 · Nano Trends
48. Epigenetic regulation of T cell exhaustion in cancer
    Tae Gun Kang, Jordan T. Johnson, Caitlin C. Zebley, Ben Youngblood · 2025 · Nature reviews. Cancer
49. The two-faces of NK cells in oncolytic virotherapy
    Marie Marotel, Mohamed S. Hasim, Ash Hagerman, Michele Ardolino · 2020 · Cytokine & Growth Factor Reviews
50. A Comprehensive Review of Recent Advancements in Cancer Immunotherapy and Generation of CAR T Cell by CRISPR-Cas9
    Md Al Saber, Partha Biswas, Dipta Dey, Md. Abu Kaium, Md. Aminul Islam, Miss Ismoth Ara Tripty, MD. Hasanur Rahman, Tanjim Ishraq Rahaman, Md. Yeaman Biswas, Priyanka Paul et al. · 2021 · Processes
51. Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer
    Qiaorui Tan, Sha Yin, Dongdong Zhou, Yajing Chi, Xiaochu Man, Huihui Li · 2022 · Frontiers in Oncology
52. Nanotechnology-Based Approaches to Promote Lymph Node Targeted Delivery of Cancer Vaccines
    Ruiqing He, Jie Zang, Yuge Zhao, Haiqing Dong, Yongyong Li · 2022 · ACS Biomaterials Science & Engineering
53. Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
    Xiaoxue Lang, Xiangtao Wang, Meihua Han, Yifei Guo · 2024 · International Journal of Nanomedicine
54. Single-Dose Anti–PD-L1/IL-15 Fusion Protein KD033 Generates Synergistic Antitumor Immunity with Robust Tumor-Immune Gene Signatures and Memory Responses
    Stella A. Martomo, Dan Lü, Zhanna Polonskaya, Xenia Luna, Zhikai Zhang, Sam F. Feldstein, Radovan Lumban-Tobing, Danielle K. Almstead, Faïçal Miyara, Jeegar P. Patel · 2020 · Molecular Cancer Therapeutics
55. Exosomal non-coding RNAs: Emerging roles in bilateral communication between cancer cells and macrophages
    Wenhao Li, Xiaolong Wang, Chen Li, Tong Chen, Qifeng Yang · 2021 · Molecular Therapy
56. Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
    Bailin He, Qiusui Mai, Yunyi Pang, Shikai Deng, Yi He, Rongtao Xue, Na Xu, Hongsheng Zhou, Xiaoli Liu, Xuan Li et al. · 2023 · Frontiers in Immunology
57. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy
    Yuying Dong, Mingming Zheng, Xiaoxuan Wang, Chenyue Yu, Tiantian Qin, Xuning Shen · 2023 · BMC Cancer
58. Cancer-associated venous thromboembolism: a comprehensive review
    Tingting Wan, Jia Song, Dapeng Zhu · 2025 · Thrombosis Journal
59. Fluorine-19 Cellular MRI Detection of In Vivo Dendritic Cell Migration and Subsequent Induction of Tumor Antigen-Specific Immunotherapeutic Response
    Corby Fink, Michael H. Smith, Jeffrey M. Gaudet, Ashley V. Makela, Paula J. Foster, Gregory A. Dekaban · 2019 · Molecular Imaging and Biology
60. Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy
    Yuanlin Wu, Jing Li, Parham Jabbarzadeh Kaboli, Jing Shen, Xu Wu, Yueshui Zhao, Huijiao Ji, Fukuan Du, Yejiang Zhou, Yongzhou Wang et al. · 2020 · Pharmacological Research
61. Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines
    Ruoyu Cheng, Flavia Fontana, Junyuan Xiao, Zehua Liu, Patrícia Figueiredo, Mohammad‐Ali Shahbazi, Shiqi Wang, Jing Jin, Giulia Torrieri, Jouni J. Hirvonen et al. · 2020 · ACS Applied Materials & Interfaces
62. Alternol triggers immunogenic cell death via reactive oxygen species generation
    Changlin Li, Ying Zhang, Siyuan Yan, Guoan Zhang, Wei Wei, Zhi Qi, Benyi Li · 2021 · OncoImmunology
63. Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review
    Lihui Liu, Chao Wang, Sini Li, Hua Bai, Jie Wang · 2021 · Translational Lung Cancer Research
64. Novel Genomic Insights into Body Size Evolution in Cetaceans and a Resolution of Peto’s Paradox
    Di Sun, Simin Chai, Xin Huang, Yingying Wang, Linlin Xiao, Shixia Xu, Guang Zhong Yang · 2021 · The American Naturalist
65. A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy
    Chenyu Mao, Yongfeng Ding, Nong Xu · 2021 · Frontiers in Oncology
66. The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives
    Sana Ahuja, Sufian Zaheer · 2024 · Korean Journal of Clinical Oncology
67. Priming and Propagating Anti-tumor Immunity: Focal Hypofractionated Radiation for in Situ Vaccination and Systemic Targeted Radionuclide Theranostics for Immunomodulation of Tumor Microenvironments
    Justin C. Jagodinsky, Zachary Scott Morris · 2020 · Seminars in Radiation Oncology
68. pH-Triggered Copper-Free Click Reaction-Mediated Micelle Aggregation for Enhanced Tumor Retention and Elevated Immuno–Chemotherapy against Melanoma
    Miao Deng, Rong Guo, Shuya Zang, Jingdong Rao, Mengmeng Li, Xian Tang, Chunyu Xia, Man Li, Zhirong Zhang, Qin He · 2021 · ACS Applied Materials & Interfaces
69. TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy
    Caleb González, Sarah Louise Williamson, Seth T. Gammon, Sarah E. Glazer, Joon Haeng Rhee, David R Piwnica-Worms · 2023 · Communications Biology
70. IL-15: from discovery to FDA approval
    Zihai Li, John M. Wrangle, Kai He, Jonathan Sprent, Mark P. Rubinstein · 2025 · Journal of Hematology & Oncology
71. Platelet-Derived GARP Induces Peripheral Regulatory T Cells—Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis
    Niklas Zimmer, Franziska K. Krebs, Sophia Zimmer, Heidrun Mitzel-Rink, Elena J. Kumm, Kerstin Jurk, Stephan Grabbe, Carmen Loquai, Andrea Tuettenberg · 2020 · Cancers
72. Clinical translation of immunomodulatory therapeutics
    Amanda Nash, Samira Aghlara-Fotovat, Andrea Hernández, Christopher M. Scull, Omid Veiseh A · 2021 · Advanced Drug Delivery Reviews
73. Advances in Immunomodulatory Mesoporous Silica Nanoparticles for Inflammatory and Cancer Therapies
    Bin Gu, Qin Ping Zhao, Yiran Ao · 2024 · Biomolecules
74. Cytokine sustained delivery for cancer therapy; special focus on stem cell- and biomaterial- based delivery methods
    Hossein Mehralizadeh, Ahmad Nazari, Farshid Oruji, Minoo Roostaie, Ghazaleh Hosseininozari, Omid Yazdani, Romina Esbati, Kamran Roudini · 2023 · Pathology - Research and Practice
75. Inflammation and Inflammasomes: Pros and Cons in Tumorigenesis
    Liliana-Roxana Balahura, Aida Șelaru, Sorina Dinescu, Marieta Costache · 2020 · Journal of Immunology Research
76. Present and Future of Immunotherapy for Triple-Negative Breast Cancer
    Sushmitha Sriramulu, Shivani Thoidingjam, Corey Wayne Speers, Shyam Nyati · 2024 · Cancers
77. Advances in mRNA-based drug discovery in cancer immunotherapy
    Claudia Augusta Di Trani, Myriam Fernández-Sendin, Assunta Cirella, Aina Segués, Irene Olivera, Elixabet Bolaños, Ignacio Melero, Pedro Berraondo · 2021 · Expert Opinion on Drug Discovery
78. An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
    Hongchuan Liu, Rui Wang, Duopeng An, Hui Liu, Fan Ye, Baoxian Li, Jing Zhang, Peixiang Liu, Xuyao Zhang, Sheng Yao et al. · 2021 · International Immunopharmacology
79. Platelet membrane camouflaged AIEgen ‐mediated photodynamic therapy improves the effectiveness of anti‐PD‐L1 immunotherapy in large‐burden tumors
    Jun Dai, Meng Wu, Yating Xu, Hongming Yao, Xiaoding Lou, Yuning Hong, Jian Qiang Zhou, Fan Xia, Shixuan Wang · 2022 · Bioengineering & Translational Medicine
80. Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
    Matin Ghasemi, Laleh Abbasi, Leila Ghanbari Naeini, Pajman Kokabian, Najmeh Nameh Goshay Fard, Nozar Givtaj · 2023 · Frontiers in Immunology
81. RETRACTED: Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy
    Ehsan Razeghian, Ria Margiana, Supat Chupradit, Dmitry Olegovich Bokov, Walid Kamal Abdelbasset, Faroogh Marofi, Siavash Shariatzadeh, Foad Tosan, Mostafa Jarahian · 2021 · Frontiers in Medicine · Retracted
82. Immunotherapy of cancer in single-cell RNA sequencing era: A precision medicine perspective
    Nafiseh Erfanian, Afshin Derakhshani, Saeed Nasseri, Mohammad Fereidouni, Behzad Baradaran, Neda Jalili Tabrizi, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris, Hossein Safarpour · 2021 · Biomedicine & Pharmacotherapy
83. More than Toxins—Current Prospects in Designing the Next Generation of Antibody Drug Conjugates
    Jonathan Schwach, Mustafa Abdellatif, Andreas Stengl · 2022 · Frontiers in Bioscience-Landmark
84. Research Progress of Immunotherapy for Gastric Cancer
    Zhipeng Zhang, Ningning Liu, Mingyu Sun · 2023 · Technology in Cancer Research & Treatment
85. Nanomaterials augmented bioeffects of ultrasound in cancer immunotherapy
    Xinxin Xie, Jinxia Zhang, Yuan Wang, Wanrui Shi, Rui Tang, Qingshuang Tang, Suhui Sun, Ruiqi Wu, Shuyu Xu, Mengxin Wang et al. · 2023 · Materials Today Bio
86. Intra-Tumoral Delivery of IL-27 Using Adeno-Associated Virus Stimulates Anti-tumor Immunity and Enhances the Efficacy of Immunotherapy
    Aiyan Hu, Miao Ding, Jianmin Zhu, Jin-Qing Liu, Xueliang Jeff Pan, Kalpana Ghoshal, Xue‐Feng Bai · 2020 · Frontiers in Cell and Developmental Biology
87. Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy
    Limin Tian, Tianyan Liu, Shan Jiang, Yukai Cao, Kai Kang, Han Su, Guiping Ren, Zhenzhong Wang, Wei Xiao, Deshan Li · 2021 · Gene Therapy
88. Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health
    Shivani Thoidingjam, Sushmitha Sriramulu, Svend O. Freytag, Stephen L. Brown, Jae Ho Kim, Indrin J. Chetty, Farzan Siddiqui, Benjamin Movsas, Shyam Nyati · 2023 · Translational Medicine Communications
89. Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer
    Daniel J. García-Domínguez, Soledad López-Enríquez, Gonzalo Álba, Carmen Garnacho, Carlos Jiménez‐Cortegana, Rocío Flores-Campos, Luis de la Cruz‐Merino, Nabil Hajji, Víctor Sánchez‐Margalet, Lourdes Hontecillas‐Prieto · 2024 · International Journal of Molecular Sciences
90. Antitumor effects of melanin from Lachnum YM226 and its derivative in H22 tumor-bearing mice
    Shi Fang, Jinglei Li, Ziyang Ye, Liuqing Yang, Tingting Chen, Xue Chen, Ming Ye · 2018 · MedChemComm
91. Serum IL-6 as a vital predictor of severe lung cancer
    Jian An, Qihua Gu, Liming Cao, Huaping Yang, Pengbo Deng, Chengping Hu, Min Li · 2021 · Annals of Palliative Medicine
92. BET Inhibition Enhances TNF-Mediated Antitumor Immunity
    Lisa C. Wellinger, Simon J. Hogg, Dane M. Newman, Thomas Friess, Daniela Geiss, Jessica Michie, Kelly M. Ramsbottom, Marina Bacac, Tanja Fauti, Daniel Marbach et al. · 2021 · Cancer Immunology Research
93. KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma
    Yankang Cui, Tianyi Shen, Feng Xu, Jing Zhang, Yuhao Wang, Jiajin Wu, Hengtao Bu, Dian Fu, Bo Fang, Huichen Lv et al. · 2022 · Cancer Cell International
94. The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma
    Moloud Sooreshjani, Shashwat Tripathi, Corey Dussold, Hinda Najem, John de Groot, Rimas Vincas Lukas, Amy B. Heimberger · 2023 · Cancers
95. i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists
    Matthew G. Romei, Brandon C. Leonard, Zachary Katz, Daniel Le, Yanli Yang, Eric S. Day, Christopher W. Koo, Preeti Apurve Sharma, Jack J. Bevers, Ingrid Kim et al. · 2024 · Nature Communications
96. A lipid-soluble extract of Pinellia pedatisecta Schott enhances antitumor T cell responses by restoring tumor-associated dendritic cell activation and maturation
    Yumeng Wang, Haixia Huang, Sheng Yao, Guiling Li, Congjian Xu, Yang Ye, Sui-qi Gui · 2019 · Journal of Ethnopharmacology
97. LRRK2 correlates with macrophage infiltration in pan-cancer
    Jing Yan, Wenhui Zhao, Wei Yu, Hongju Cheng, Baoliang Zhu · 2021 · Genomics
98. mRNA delivery technologies: Toward clinical translation
    Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Alicia Rodríguez‐Gascón, Ana del Pozo‐Rodríguez, Maria Ángelés Solinís · 2022 · International review of cytology
99. Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies
    Josée Golay, Alain E. Andrea · 2020 · Antibodies
100. Targeting platelet-tumor cell interactions: a novel approach to cancer therapy
     Safia Obaidur Rab, Farag M. A. Altalbawy, Ashok Kumar Bishoyi, Suhas Ballal, Mohamed Abdul Kareem, Abhayveer Singh, Aziz Kubaev, Hamed Soleimani Samarkhazan, Saeede Bagheri · 2025 · Medical Oncology